Missing/wrong data?
Log in to edit
Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort.
scientific article
Author/s
author: Ilijas Jelčić, Arseny A Sokolov, Roland Martin, Michael Linnebank, Björn Zörner
Work details
Publication date
March 1, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.